REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Astrazeneca Indonesia (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: PT Astrazeneca Indonesia Profile Updated: February 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

PT Astrazeneca Indonesia is based in Indonesia, with the head office in South Jakarta. The company operates in the Pharmaceutical Preparation Manufacturing sector. It was first established on August 06, 1971. It currently has a total number of 100 (estimated) employees. The company’s latest financial report indicates a net sales revenue increase of 3.74% in 2023. Its total assets grew by 2.57% over the same period.

Headquarters
Perkantoran Hijau Arkadia, Kav 88
South Jakarta; Jakarta; Postal Code: 12520

Contact Details: Purchase the PT Astrazeneca Indonesia report to view the information.

Website: http://www.astrazeneca.com

Basic Information
Total Employees:
Purchase the PT Astrazeneca Indonesia report to view the information.
Outstanding Shares:
Purchase the PT Astrazeneca Indonesia report to view the information.
Registered Capital:
Purchase the PT Astrazeneca Indonesia report to view the information.
Incorporation Date:
August 06, 1971
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Astrazeneca Indonesia report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
3.74%
Total operating revenue
3.74%
Total assets
2.57%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?